Does DUPILUMAB Cause Injection site mass? 2,243 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,243 reports of Injection site mass have been filed in association with DUPILUMAB (Dupixent). This represents 0.6% of all adverse event reports for DUPILUMAB.
2,243
Reports of Injection site mass with DUPILUMAB
0.6%
of all DUPILUMAB reports
0
Deaths
49
Hospitalizations
How Dangerous Is Injection site mass From DUPILUMAB?
Of the 2,243 reports, 49 (2.2%) required hospitalization, and 1 (0.0%) were considered life-threatening.
Is Injection site mass Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DUPILUMAB. However, 2,243 reports have been filed with the FAERS database.
What Other Side Effects Does DUPILUMAB Cause?
Pruritus (44,279)
Dermatitis atopic (33,670)
Product use in unapproved indication (33,452)
Rash (30,895)
Injection site pain (27,799)
Drug ineffective (23,712)
Dry skin (20,239)
Eczema (20,020)
Product dose omission issue (18,189)
Condition aggravated (16,459)
What Other Drugs Cause Injection site mass?
EXENATIDE (3,506)
GLATIRAMER (2,172)
ETANERCEPT (2,101)
NALTREXONE (1,849)
TIRZEPATIDE (1,386)
LEUPROLIDE (1,359)
DULAGLUTIDE (1,319)
EVOLOCUMAB (1,254)
ADALIMUMAB (915)
OCTREOTIDE (880)
Which DUPILUMAB Alternatives Have Lower Injection site mass Risk?
DUPILUMAB vs DURAGESIC
DUPILUMAB vs DUROGESIC
DUPILUMAB vs DUROTEP MT
DUPILUMAB vs DURVALUMAB
DUPILUMAB vs DUTASTERIDE